What one share of Clene holds
We are a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (“CSN®”) therapeutics. CSN® therapeutics are comprised of atoms of transition elements that, when assembled in nanocrystal form, possess unusually high, unique catalytic activities not present in those same elements in bulk form.
Clene’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.02 |
|---|---|
| Profit | −$3.51 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.42 |
| Cash and investments | $0.76 |
| Debt | $1.47 |
| Book value | −$1.94 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$18.61 | $0.34 | −$15.54 | — | −$78.09 |
| 2020 | $0.24 | −$22.03 | $0.44 | −$22.07 | — | — |
| 2021 | $0.23 | −$3.16 | $0.43 | −$11.68 | — | $4.04 |
| 2022 | $0.15 | −$9.18 | $1.59 | −$13.55 | — | $0.87 |
| 2023 | $0.12 | −$9.43 | $0.06 | −$5.81 | — | $2.09 |
| 2024 | $0.05 | −$5.67 | $0.00 | −$3.07 | — | −$1.09 |
| 2025 | $0.02 | −$2.65 | $0.00 | −$1.89 | — | −$1.62 |
Common questions about Clene
How much does one share of Clene earn?
Over the last 12 months, Clene lost $3.51 for each share on $0.02 of sales.
Does Clene pay a dividend?
Clene didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Clene’s book value per share?
Clene’s book value is negative (−$1.94 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Clene have?
Each share of Clene has $0.76 of cash and investments and $1.47 of debt, as of June 30, 2026.
What is Clene’s free cash flow per share?
−$1.42 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Clene bought back shares?
Clene’s share count rose about 1036% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.